{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"16"}],"units":"Participants"}],"groups":[{"description":"Fludarabine, Cyclophosphamide; Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil\n\ngraft-versus-tumor prophylaxis therapy\n\ncyclophosphamide\n\ncyclosporine\n\nfludarabine phosphate\n\nmycophenolate mofetil\n\numbilical cord blood transplantation\n\nradiation therapy","id":"OG000","title":"Conditioning Therapy Followed by TBI"}],"paramType":"NUMBER","reportingStatus":"POSTED","timeFrame":"3 months","title":"Number of Participants Who Developed Acute Graft Versus Host Disease","type":"SECONDARY","unitOfMeasure":"participants"}